Rhythm Pharmaceuticals Obtains $8,000,000 Series B Round

  • Feed Type
  • Date
    11/27/2012
  • Company Name
    Rhythm Pharmaceuticals
  • Mailing Address
    855 Boylston Street, 11th Floor Boston, MA 02116
  • Company Description
    Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases.
  • Website
    http://www.rhythmtx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Rhythm will use the proceeds to further develop its small-peptide therapeutics for metabolic diseases.
  • M&A Terms
  • Venture Investor
    Pfizer Venture Investments

By posting a comment, you agree to our terms and conditions.